Skip to main content
. 2021 Jun 14;188(2):369–377. doi: 10.1007/s10549-021-06197-5

Fig. 3.

Fig. 3

Kaplan–Meier plot of progression-free survival at the final assessment in the intention-to-treat population based on central tumor evaluation. Numbers of patients at risk are displayed at the bottom of the figure. The stratified hazard was calculated by assigned taxane, tumor progression, and tumor endocrine status